Efficacy of Jadwar (Delphinium denudatum Wall. ex Hook.f. & Thomson) in subclinical hypothyroid patients: A single-blind, randomized placebo controlled trial

Key Points

• Jadwar demonstrates notable efficacy in improving thyroid function among patients with subclinical hypothyroidism, indicating potential benefits for this population.
• The trial measured thyroid hormone levels, showing improvement in treatment groups compared to placebo, with a significant difference noted.
• Conducted as a single-blind randomized controlled trial, this study aimed to evaluate the effectiveness of jadwar against a placebo.
• These findings may support the incorporation of jadwar in treatment protocols for subclinical hypothyroidism, pending larger studies.